Active

GenomiX

Switched

BE0757949684

Rechtspersoon Private limited company 1 establishment

Allée de la Cense-Rouge 9, 4031 Liège

Active for

5 year, 9 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ -1,109

▲ 16% vs 2024

Profit

Healthy

€ 9,134

Debts

Low

€ 88,350

▲ 3% vs 2024

GenomiX from Liège, company number BE0757949684, closed financial year 2025 with a result of € 9,134 after tax. For that financial year GenomiX recorded a gross margin of € -1,109 and equity of € 255,524. Compared with financial year 2024, the result moved from € 9,135 to € 9,134. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What happened at GenomiX?

What happened at GenomiX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 9,134. filed late Source: NBB ↗
  • Benoît GLAUDE became a director. NBB
  • New establishment in Liège. KBO
  • Christophe GREFFE became a director. NBB
  • Nicolas POELST became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 10,088 loss in 2021 to € 9,134 profit in 2025.

Best year ever: 2022, with € 13,027 profit.

A new publication or filing at GenomiX? We notify you, reason included.

Follow GenomiX

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Christophe GREFFE
Benoît GLAUDE
Nicolas POELST
GenomiX

Behind GenomiX are Christophe GREFFE, Benoît GLAUDE and Nicolas POELST. It owns 62% of REPROBIOL itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Christophe GREFFE

Director

Also active at: GeneriX

since 2020

Benoît GLAUDE

Director

Also active at: BIO-MIX, REPROBIOL

since 2023

Nicolas POELST

Director

Also active at: X-RIS, GeneriX

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Allée de la Cense-Rouge 9

4031 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0757.949.684
VAT number
BE 0757.949.684
Registered office
Allée de la Cense-Rouge 9, 4031 Liège
Names & denominations
GenomiX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
10 November 2020
Peppol
Not registered
Contact
cg@generix.be

Frequently asked questions

What is the enterprise number of GenomiX?
The enterprise number of GenomiX is BE0757949684.
What is the address of GenomiX?
The registered office of GenomiX is located at Allée de la Cense-Rouge 9, 4031 Liège.
When was GenomiX founded?
GenomiX was founded on 10 November 2020.
Does GenomiX have a website?
No website is currently known for GenomiX.
How much profit did GenomiX make in 2025?
GenomiX posted a profit after taxes of € 9,134 in financial year 2025.
What is the revenue of GenomiX?
As a small company, GenomiX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,109.
Where can I find the annual accounts of GenomiX?
GenomiX files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of GenomiX?
According to the 2025 annual accounts, the directors of GenomiX are: Christophe GREFFE, Benoît GLAUDE, Nicolas POELST.
Who owns GenomiX?
Behind GenomiX are Christophe GREFFE, Benoît GLAUDE and Nicolas POELST. It owns 62% of REPROBIOL itself.